Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Radioimmunotherapy of lymphoma using anti-CD20 antibodies

Radioimmunotherapy of lymphoma using anti-CD20 antibodies

US Patent 6015542 · Granted Jan 18, 2000

Estimated economic value: $9,719,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Terameprocol and nordihydroguaiaretic acid (NDGA) derivatives as coronavirus ant2023
Anti-hypertensive and cholesterol-lowering fixed-dose combination and method of 2023
Transcutaneous neural stimulation device2017
Method of making a consumable product with purified embryonated Trichuris suis o2017
Computer-aided detection (CAD) system for personalized disease detection, assess2015
Use of immunomodulators for the treatment of cancer2012
Use of immunomodulators for the treatment of cancer2012
Wireless communications module2010
Internal marker device for identification of biological substances2010
Patient-specific dosimetry2010
Internal marker device for identification of biological substances2003
Radioimmunotherapy of lymphoma using anti-CD20 antibodies2003